Founders ask me a version of the same question all the time: is it too late to build a doctor booking platform, has that ship not sailed with Zocdoc and Doctolib? Here is the mistake buried in that question. It assumes a proven category is a closed one. It is the opposite. A category that a well-known brand has already validated is the safest kind to enter, because you no longer have to convince the world that people will book doctors online. They already do. The only real question left is where the map still has blank spaces, and in 2027 it has plenty.
The Green-Light Test: three signals that say build
I do not tell founders "yes, build it" based on enthusiasm. I run what I call the Green-Light Test. Three signals have to be present at once. If all three are green, the timing is genuinely good. If one is red, you fix that before you write a line of code.
The category is proven, so you skip the hardest sale
The most expensive thing in any new market is teaching people a new behaviour. Whoever went first in online doctor booking spent years and enormous marketing budgets convincing patients that tapping a slot on a phone was as safe as calling the receptionist. That work is done. Zocdoc proved it in the US, Doctolib proved it across France, Germany and neighbouring markets. In 2027, a patient who wants a dermatologist next Tuesday already reaches for their phone by instinct. You inherit that instinct for free. That is a gift, and it is the single strongest argument for building now rather than five years ago.
There is a second, quieter gift that comes with a proven category: doctors have been educated too. A few years ago, convincing a busy practice to put its calendar online was a hard sell in itself. Today many doctors already understand online booking, may already use a tool for it, and have opinions about what a good one looks like. That lowers your supply-side friction, the hardest rung on the ladder, because you are not explaining the concept, you are offering a better or better-fit version of something they already accept. In an underserved niche, "the one built for how you actually work" is a far easier pitch than "the first of its kind."
The map is strong in the centre and thin at the edges
Here is what founders miss when they say the market is saturated: they are looking at it from a big city. Yes, the leaders are dense in major metros and in the most popular specialties. But marketplaces concentrate, they do not blanket. Step outside the flagship cities, or into a specific specialty, or into a whole country with no dominant player, and the phone is still the booking method. That is the gap.
Region by region in 2027, the pattern repeats. The US has powerful incumbents and still a long list of underserved regions and niche specialties. The UK has an NHS under real pressure, which pushes patients toward anything that makes booking easier. Continental Europe has Doctolib as a clear leader but genuinely uneven coverage across countries and specialties. The Netherlands and its neighbours have room for focused local players who understand the local system. Everywhere, the shape is the same: strong in the middle, open at the edges. Our guide to building across the US, UK and EU goes region by region on exactly this.
Notice what this map does not say. It does not say "there is no competition," because there is, and it is strong where it stands. It says the competition is uneven, and uneven is all a focused founder needs. You are not trying to flip a served core, you are claiming an edge nobody is defending. That is a fundamentally easier fight, and it is why the honest read of 2027 is optimism with discipline rather than either hype or despair.
Telehealth widened the door
There is a structural tailwind too. Since the pandemic, patients expect a choice between a video visit and an in-person one, and they expect to make that choice at the moment of booking. A platform launching in 2027 can offer both from day one instead of bolting video onto an in-person tool years later, which is what many older systems are still doing awkwardly. That is a real advantage, and it is worth deciding early which to lead with, a decision we unpack in telehealth versus in-person booking.
Tell us what you have in mind. We turn AI prototypes and fresh ideas into shipped, scalable products, from India, for the US and UK.
AI made the build cheaper, not the business easier
I want to be precise here because it is easy to oversell. AI genuinely compresses the early phases of a build, the scoping, the documentation, the UI and UX ideation, turning those concepts into front-end code, planning the microinteractions. In our own work that is roughly a forty percent saving on those phases, which is a real reason a focused platform is cheaper to launch in 2027 than it was a few years back. AI also enables smarter matching and lighter triage inside the product.
But AI does not conjure your doctors, and it does not make you compliant. It writes code, it does not run a healthcare business. So treat it as an accelerator bolted to the front of a serious build, not as the build itself. This is the same line I draw everywhere: the tooling got faster, the business got no easier.
What everyone gets wrong: trying to beat the leader everywhere
The failure mode I see most is a founder who wants to out-Zocdoc Zocdoc in Zocdoc's best cities. That is a fight you lose on marketing spend alone. The correct ambition is narrower and far more winnable: own one specialty in one place better than anyone else. Marketplaces are won locally first and expanded outward, never the reverse. A concrete example of the right shape: rather than "a national doctor booking app," aim for "the booking platform every physiotherapist in one region actually uses." That is small enough to fill with real supply, specific enough to have an unserved gap, and defensible once you own it. From there you expand. That is precisely the local-first discipline we describe in the marketplace go-to-market guide.
So, should you build one in 2027?
Run the Green-Light Test honestly. If you can access a real supply of doctors in a specific niche, that niche has patients the current options underserve, and you can meet the HIPAA or GDPR bar for your region, then the timing is genuinely good and the proven category is working in your favour. If any of those three is missing, fix it before you build, because no amount of polished app compensates for a missing signal.
When the signals are green, our build guide for the US, UK and EU is the practical next step, and the business model breakdown shows how the economics work once you have supply. We help founders launch lean and honest in an unserved niche, from India for US, UK and EU markets, with the code and accounts in your name from day one. My last word is the one I give everyone: launching is one percent of the journey. Build for the ninety-nine percent that comes after, and 2027 is a good year to start.
Frequently asked questions
Why build a doctor booking platform in 2027?
Because the category is proven and the map still has gaps. Zocdoc validated online doctor booking in the US and Doctolib did the same across Europe, so you are not inventing a behaviour, you are serving one that already exists. At the same time, most cities, specialties and regions outside the leaders' strongholds still book appointments by phone. A proven category plus an unserved niche is the healthiest reason to build.
Is the doctor booking market not already saturated?
Nationally in a few places, locally almost nowhere. The leaders concentrate in dense metros and popular specialties. Smaller cities, specific specialties, and whole countries with no dominant player are wide open. Saturation is a myth that only looks true from a big-city vantage point.
What regions have the clearest gaps in 2027?
The US has strong incumbents but plenty of underserved regions and niches. The UK has NHS pressure driving demand for easier booking. Continental Europe has Doctolib as a leader but uneven coverage, and the Netherlands and neighbouring markets have room for focused local players. The pattern everywhere is the same: strong in the centre, thin at the edges.
When does launching a doctor booking platform actually make sense?
When three things line up: you can access a supply of doctors in a specific niche, that niche has patients underserved by current options, and you can meet the compliance bar for the region. If you have doctor relationships in an unserved specialty and can handle HIPAA or GDPR, the timing is good. If you have none of those, a shiny app will not save you.
Does telehealth change the case for building in 2027?
Yes, it strengthens it. Since the pandemic, patients expect to choose between a video visit and an in-person one, and many booking platforms now handle both. Building in 2027 means you can offer telehealth and in-person from the start rather than bolting video on later, which is a real advantage over older tools.
How does AI affect the opportunity?
AI lowers the cost and time to build the early phases, so a focused platform is cheaper to launch than it was a few years ago. It also enables smarter matching and triage. But AI does not create your supply of doctors or your compliance posture, so treat it as an accelerator on the build, not a substitute for the business.
Is it too late to compete with Zocdoc or Doctolib?
Head-on in their strongest cities, probably. In a focused niche or an underserved region, not at all. The right frame is not "beat Zocdoc everywhere" but "own one specialty in one place better than anyone." Marketplaces are won locally first, and incumbents are always thin somewhere.
How can appico help me launch in 2027?
We help you pick a winnable niche, scope the build around real doctor supply and compliance, and ship a lean first version, from India for US, UK and EU founders, with source code and accounts in your name. We would rather help you launch small in an unserved niche and grow than help you launch broad against an incumbent and stall.
“Disciplined, committed, over-delivers. Three years in, I would re-hire any day.”
“A factory of ideas.”
“A fantastic-looking and performing website.”
Talk to the team, we reply within 24 hours, and the first consultation is free.
Start a conversation →